Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

China Generic Drugmakers Poaching Indian Execs

publication date: Sep 3, 2015
In the competition between China and India pharmas, China's generic drug industry leads in the supply of APIs to global drugmakers, but India supplies more finished generic drugs to the world's marketplace. That may be changing. According to press reports, China drugmakers have begun hiring experienced Indian pharma execs, offering them two to three times their present salaries. The China companies are willing to pay at these levels because the Indian professionals have two skills the Chinese want: drug formulation experience and English. China's drugmakers want help as they target the western world's lucrative generic drug market. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022